Cost-utility of exercise therapy in patients with hip osteoarthritis in primary care: Osteoarthritis and Cartilage

S. S. Tan, C. H. Teirlinck, Joost Dekker, L. M. A. Goossens, A.M. Bohnen, J.A.N. Verhaar, P.P. van Es, B.W. Koes, S.M.A. Bierma-Zeinstra, P.A.J. Luijsterburg, M.A. Koopmanschap

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective: To determine the cost-effectiveness (CE) of exercise therapy (intervention group) compared to 'general practitioner (GP) care' (control group) in patients with hip osteoarthritis (OA) in primary care. Method: This cost-utility analysis was conducted with 120 GPs in the Netherlands from the societal and healthcare perspective. Data on direct medical costs, productivity costs and quality of life (QoL) was collected using standardised questionnaires which were sent to the patients at baseline and at 6, 13, 26, 39 and 52 weeks follow-up. All costs were based on Euro 2011 cost data. Results: A total of 203 patients were included. The annual direct medical costs per patient were significantly lower for the intervention group ((sic) 1233) compared to the control group ((sic) 1331). The average annual societal costs per patient were lower in the intervention group ((sic) 2634 vs (sic) 3241). Productivity costs were higher than direct medical costs. There was a very small adjusted difference in QoL of 0.006 in favour of the control group (95% CI: -0.04 to +0.02). Conclusion: Our study revealed that exercise therapy is probably cost saving, without the risk of noteworthy negative health effects. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)581-588
Number of pages8
JournalOsteoarthritis and Cartilage
Volume24
DOIs
Publication statusPublished - 2016

Cite this

Tan, S. S., Teirlinck, C. H., Dekker, J., Goossens, L. M. A., Bohnen, A. M., Verhaar, J. A. N., ... Koopmanschap, M. A. (2016). Cost-utility of exercise therapy in patients with hip osteoarthritis in primary care: Osteoarthritis and Cartilage. Osteoarthritis and Cartilage, 24, 581-588. https://doi.org/10.1016/j.joca.2015.11.010
Tan, S. S. ; Teirlinck, C. H. ; Dekker, Joost ; Goossens, L. M. A. ; Bohnen, A.M. ; Verhaar, J.A.N. ; van Es, P.P. ; Koes, B.W. ; Bierma-Zeinstra, S.M.A. ; Luijsterburg, P.A.J. ; Koopmanschap, M.A. / Cost-utility of exercise therapy in patients with hip osteoarthritis in primary care : Osteoarthritis and Cartilage. In: Osteoarthritis and Cartilage. 2016 ; Vol. 24. pp. 581-588.
@article{783e1c681d4849799ea9e24031662e7e,
title = "Cost-utility of exercise therapy in patients with hip osteoarthritis in primary care: Osteoarthritis and Cartilage",
abstract = "Objective: To determine the cost-effectiveness (CE) of exercise therapy (intervention group) compared to 'general practitioner (GP) care' (control group) in patients with hip osteoarthritis (OA) in primary care. Method: This cost-utility analysis was conducted with 120 GPs in the Netherlands from the societal and healthcare perspective. Data on direct medical costs, productivity costs and quality of life (QoL) was collected using standardised questionnaires which were sent to the patients at baseline and at 6, 13, 26, 39 and 52 weeks follow-up. All costs were based on Euro 2011 cost data. Results: A total of 203 patients were included. The annual direct medical costs per patient were significantly lower for the intervention group ((sic) 1233) compared to the control group ((sic) 1331). The average annual societal costs per patient were lower in the intervention group ((sic) 2634 vs (sic) 3241). Productivity costs were higher than direct medical costs. There was a very small adjusted difference in QoL of 0.006 in favour of the control group (95{\%} CI: -0.04 to +0.02). Conclusion: Our study revealed that exercise therapy is probably cost saving, without the risk of noteworthy negative health effects. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.",
author = "Tan, {S. S.} and Teirlinck, {C. H.} and Joost Dekker and Goossens, {L. M. A.} and A.M. Bohnen and J.A.N. Verhaar and {van Es}, P.P. and B.W. Koes and S.M.A. Bierma-Zeinstra and P.A.J. Luijsterburg and M.A. Koopmanschap",
note = "M1 - 4 ISI Document Delivery No.: DH1NR Times Cited: 2 Cited Reference Count: 23 Tan, S. S. Teirlinck, C. H. Dekker, J. Goossens, L. M. A. Bohnen, A. M. Verhaar, J. A. N. van Es, P. P. Koes, B. W. Bierma-Zeinstra, S. M. A. Luijsterburg, P. A. J. Koopmanschap, M. A. Koes, Bart/K-4614-2016 Koes, Bart/0000-0002-0450-9969 Netherlands Organisation for Health Research and Development [170992402] This research was financial supported by the Netherlands Organisation for Health Research and Development (grant 170992402). The study sponsor did not have any role in the study design, collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. 2 1 4 ELSEVIER SCI LTD OXFORD OSTEOARTHR CARTILAGE",
year = "2016",
doi = "10.1016/j.joca.2015.11.010",
language = "English",
volume = "24",
pages = "581--588",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "W.B. Saunders Ltd",

}

Tan, SS, Teirlinck, CH, Dekker, J, Goossens, LMA, Bohnen, AM, Verhaar, JAN, van Es, PP, Koes, BW, Bierma-Zeinstra, SMA, Luijsterburg, PAJ & Koopmanschap, MA 2016, 'Cost-utility of exercise therapy in patients with hip osteoarthritis in primary care: Osteoarthritis and Cartilage' Osteoarthritis and Cartilage, vol. 24, pp. 581-588. https://doi.org/10.1016/j.joca.2015.11.010

Cost-utility of exercise therapy in patients with hip osteoarthritis in primary care : Osteoarthritis and Cartilage. / Tan, S. S.; Teirlinck, C. H.; Dekker, Joost; Goossens, L. M. A.; Bohnen, A.M.; Verhaar, J.A.N.; van Es, P.P.; Koes, B.W.; Bierma-Zeinstra, S.M.A.; Luijsterburg, P.A.J.; Koopmanschap, M.A.

In: Osteoarthritis and Cartilage, Vol. 24, 2016, p. 581-588.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Cost-utility of exercise therapy in patients with hip osteoarthritis in primary care

T2 - Osteoarthritis and Cartilage

AU - Tan, S. S.

AU - Teirlinck, C. H.

AU - Dekker, Joost

AU - Goossens, L. M. A.

AU - Bohnen, A.M.

AU - Verhaar, J.A.N.

AU - van Es, P.P.

AU - Koes, B.W.

AU - Bierma-Zeinstra, S.M.A.

AU - Luijsterburg, P.A.J.

AU - Koopmanschap, M.A.

N1 - M1 - 4 ISI Document Delivery No.: DH1NR Times Cited: 2 Cited Reference Count: 23 Tan, S. S. Teirlinck, C. H. Dekker, J. Goossens, L. M. A. Bohnen, A. M. Verhaar, J. A. N. van Es, P. P. Koes, B. W. Bierma-Zeinstra, S. M. A. Luijsterburg, P. A. J. Koopmanschap, M. A. Koes, Bart/K-4614-2016 Koes, Bart/0000-0002-0450-9969 Netherlands Organisation for Health Research and Development [170992402] This research was financial supported by the Netherlands Organisation for Health Research and Development (grant 170992402). The study sponsor did not have any role in the study design, collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. 2 1 4 ELSEVIER SCI LTD OXFORD OSTEOARTHR CARTILAGE

PY - 2016

Y1 - 2016

N2 - Objective: To determine the cost-effectiveness (CE) of exercise therapy (intervention group) compared to 'general practitioner (GP) care' (control group) in patients with hip osteoarthritis (OA) in primary care. Method: This cost-utility analysis was conducted with 120 GPs in the Netherlands from the societal and healthcare perspective. Data on direct medical costs, productivity costs and quality of life (QoL) was collected using standardised questionnaires which were sent to the patients at baseline and at 6, 13, 26, 39 and 52 weeks follow-up. All costs were based on Euro 2011 cost data. Results: A total of 203 patients were included. The annual direct medical costs per patient were significantly lower for the intervention group ((sic) 1233) compared to the control group ((sic) 1331). The average annual societal costs per patient were lower in the intervention group ((sic) 2634 vs (sic) 3241). Productivity costs were higher than direct medical costs. There was a very small adjusted difference in QoL of 0.006 in favour of the control group (95% CI: -0.04 to +0.02). Conclusion: Our study revealed that exercise therapy is probably cost saving, without the risk of noteworthy negative health effects. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

AB - Objective: To determine the cost-effectiveness (CE) of exercise therapy (intervention group) compared to 'general practitioner (GP) care' (control group) in patients with hip osteoarthritis (OA) in primary care. Method: This cost-utility analysis was conducted with 120 GPs in the Netherlands from the societal and healthcare perspective. Data on direct medical costs, productivity costs and quality of life (QoL) was collected using standardised questionnaires which were sent to the patients at baseline and at 6, 13, 26, 39 and 52 weeks follow-up. All costs were based on Euro 2011 cost data. Results: A total of 203 patients were included. The annual direct medical costs per patient were significantly lower for the intervention group ((sic) 1233) compared to the control group ((sic) 1331). The average annual societal costs per patient were lower in the intervention group ((sic) 2634 vs (sic) 3241). Productivity costs were higher than direct medical costs. There was a very small adjusted difference in QoL of 0.006 in favour of the control group (95% CI: -0.04 to +0.02). Conclusion: Our study revealed that exercise therapy is probably cost saving, without the risk of noteworthy negative health effects. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

U2 - 10.1016/j.joca.2015.11.010

DO - 10.1016/j.joca.2015.11.010

M3 - Article

VL - 24

SP - 581

EP - 588

JO - Osteoarthritis and Cartilage

JF - Osteoarthritis and Cartilage

SN - 1063-4584

ER -